Academics May Use AI To Greenlight Research Projects

Academics May Use AI To Greenlight Research Projects

Academics May Use AI To Greenlight Research Projects

science, chemistry, medicine and people concept - close up of young scientist with chemical sample taking notes on clipboard and making test or research in laboratory over molecular structure

Using AI, researchers and executives can evaluate which areas of study have the best chance of translating to clinical trials.

Written By
David Curry
David Curry
Oct 18, 2019
2 minute read

Artificial intelligence may be making more inroads into how scientific research is conducted, with a new tool able to predict which research projects are most likely to move to a clinical trial.

The model, developed by colleagues at the Office of Portfolio Analysis (OPA), a part of the National Institutes of Health (NIH) responsible for evaluating and prioritizing research, aims to reduce the period of time between discovery and clinical application with an ‘Approximate Potential to Translate’ (APT) metric.

SEE ALSO: Why AI Has A Star Role In Future Of Energy

This metric utilizes the OPA’s massive open citation collection, which consists of over 420 million citation links, to provide a highly accurate APT value. From this, researchers and executives can evaluate which areas of study have the best chance of translating to clinical trials, and which are likely to sit unused for decades.

While the OPA is not selling the APT as a substitute for human expertise, it should provide researchers with far more information on the relevance of the study to the wider scientific community.

The APT will be used alongside a Relative Citation Ratios (RCRs) metric, which measures the scientific influence of the article. This metric has already been widely adopted by the scientific community, and the OPA expects the same to happen with the APT metric.

AI is already being deployed in many areas of research, as a way to scan through millions of research papers to find a relevant article, as an assistant able to come up with new innovations, and as a detection tool for diabetes and other diseases.

David Curry

David is a technology writer with several years experience covering all aspects of IoT, from technology to networks to security.

Recommended for you...

Is AI Compute Becoming the Next Bottleneck?
Akhil Verghese
Apr 20, 2026
Real-time Analytics News for the Week Ending April 19
Building AI Operations: A Practical Guide
Robin Kamen
Apr 16, 2026
Why 2026 Will Be the Year Agentic Orchestration Delivers
Eran Sher
Apr 15, 2026

Featured Resources from Cloud Data Insights

Is AI Compute Becoming the Next Bottleneck?
Akhil Verghese
Apr 20, 2026
Real-time Analytics News for the Week Ending April 19
Why Digitizing Leadership Standard Work Is No Longer Optional in Manufacturing
Renato Basso
Apr 17, 2026
Building AI Operations: A Practical Guide
Robin Kamen
Apr 16, 2026
RT Insights Logo

Analysis and market insights on real-time analytics including Big Data, the IoT, and cognitive computing. Business use cases and technologies are discussed.

Property of TechnologyAdvice. © 2026 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.